The guideline for the treatment and prevention of lower respiratory tract infections caused by human respiratory syncytial virus (2024 edition)

Human respiratory syncytial virus (RSV) is a major pathogen causing lower respiratory tract infections in humans. It is particularly a common cause of hospitalization among high-risk groups such as infants, tots, and the old people, imposing a heavy burden on families and society. The standardized treatment and prevention of this disease are increasingly emphasized by healthcare professionals. However, there are currently no standardized guidelines in China for lower respiratory tract infections caused by RSV. Therefore, our group for this guideline has developed the "Guidelines for the treatment and prevention of lower respiratory tract infections caused by human respiratory syncytial virus (2024 edition)" based on the latest evidence-based medical evidence and guideline development methods. The aim is to provide guidance to relevant healthcare professionals and improve prevention and treatment levels.

人呼吸道合胞病毒（RSV）是引起人类下呼吸道感染的主要病原体。特别在婴幼儿及老年人等高危人群中，RSV所致的下呼吸道感染是住院的最常见原因之一，给家庭和社会造成了沉重负担。如何对该疾病进行规范治疗和预防日益受到医务工作者的重视，目前我国尚无针对RSV引起人下呼吸道感染的规范化防治指南。因此，本指南制订专家组基于当前RSV感染防治最新循证医学证据，根据循证指南制定方法，就RSV所致下呼吸道感染的治疗及预防相关临床问题制订了《人呼吸道合胞病毒下呼吸道感染治疗及预防指南（2024版）》，旨在为相关医务工作者提供指导，提高RSV所致下呼吸道感染防治水平。.